WHO ICTRP trial
Persistence of gastrointestinal symptoms in irritable bowel syndrome and…
ISRCTN30800023 · International Standard Randomised Controlled Trial Number (ISRCTN) · Recruiting
Key facts
| Trial ID | ISRCTN30800023 |
|---|---|
| Public title | Persistence of gastrointestinal symptoms in irritable bowel syndrome and ulcerative colitis: from risk factors to modification |
| Scientific title | Persistence of gastrointestinal symptoms in irritable bowel syndrome and ulcerative colitis: a 3-arm randomised controlled trial |
| Primary sponsor | University Medical Center Hamburg-Eppendorf |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | Germany |
| Conditions | Gastrointestinal symptoms in patients with irritable bowel syndrome or ulcerative colitis Digestive System |
| Interventions | Current intervention as of 26/11/2021: We will use the design of a three-arm randomised-controlled trial (RCT). A fixed randomisation schedule, stratified by diagnostic group and sex, will be programmed and conducted electronically… |
| Registration date | Jul 21, 2021 |
| Target size | 234 |
| Secondary IDs | Nil known;Nil known;DFG grant numbers LO 766/22-1 and LO 368/11-1 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: